![](https://www.pymnts.com/wp-content/uploads/2023/04/payments-partners.jpg)
Akerman announced the growth of its Washington, D.C. office with the addition of Corporate Partner Austin Ownbey. Ownbey joins Akerman as a specialist in antitrust counseling and Hart-Scott-Rodino (HSR) filings, bringing experience in competition and antitrust issues to the firm.
An accomplished antitrust regulatory practitioner, Ownbey provides counsel on a wide range of competition and antitrust matters, including merger reviews and enforcement issues before competition agencies in the United States and globally. His expertise spans multiple industries such as healthcare, pharmaceuticals, private equity, venture capital, technology, and energy.
Throughout his career, Ownbey has represented clients before key regulatory bodies including the U.S. Department of Justice, Antitrust Division (DOJ), the Federal Trade Commission (FTC), state attorneys general, and foreign antitrust enforcement agencies. He is particularly adept at guiding clients through the HSR merger review process and other merger control filings.
Ownbey’s background includes experience as a staff attorney at the FTC, where he handled merger and conduct investigations and consumer protection litigation. His practice also extends to advising cannabis clients on licensing processes and compliance with regulatory requirements across the United States.
“Austin brings new depth and breadth to our national corporate practice, and we are thrilled he is joining our partnership,” said Corporate Practice Group Co-Chair Jonathan Awner.
Source: Akerman
Featured News
NFL Found Guilty of Antitrust Violations in ‘Sunday Ticket’ Trial, Must Pay $4.8 Billion
Jun 27, 2024 by
CPI
StarKist and Former Bumble Bee Foods Owner Settle US Price-Fixing Suit
Jun 27, 2024 by
CPI
Senate Probes Oil Giants for Price-Fixing with OPEC
Jun 27, 2024 by
CPI
Spain to Lodge Anti-Competitive Complaint Against French Rail Operator Ouigo
Jun 27, 2024 by
CPI
Jury Deliberates NFL’s ‘Sunday Ticket’ Class-Action Lawsuit
Jun 27, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Private Equity Roll-Up Schemes
Jun 28, 2024 by
CPI
The FTC’s Focus on Private Equity is Warranted
Jun 28, 2024 by
CPI
Unraveling the Roll-Up: Private Equity’s Misunderstood Investment Strategy
Jun 28, 2024 by
CPI
Antitrust Focus on Private Equity Funds and Serial Acquisitions
Jun 28, 2024 by
CPI
Private Equity Roll-Ups Amidst Heightened Antitrust Enforcement
Jun 28, 2024 by
CPI